# J. Erik Giphart

> J. Erik Giphart is a Dutch biomedical engineer and the chief executive of ArcScan whose career has moved from academic biomechanics laboratories to commercial medical imaging. After earning an electrical engineering degree at Delft and a PhD at Boston University, he built research environments for studying human motion, led a high-speed biplane fluoroscopy program in Colorado, moved into medical-device development, and joined ArcScan in 2019. He became CEO in July 2024, with a stated focus on practical product improvements, customer service, operational efficiency, and further development of ArcScan's ophthalmic ultrasound technology.

- **Role:** Director and Chief Executive Officer at ArcScan, Inc.
- **Organizations:** ArcScan, Inc., Evergreen Research, Inc., Halifax Biomedical Inc., Steadman Philippon Research Institute, Boston University, Innosphere Ventures
- **Nationality:** Dutch
- **Education:** MSc in Electrical Engineering, specializing in Information Theory, Delft University of Technology, PhD in Biomedical Engineering, Boston University
- **Known for:** Published more than 30 peer-reviewed articles across engineering and clinical journals., Built advanced academic research environments including a virtual-reality lab and a BioMotion Lab with a 1,000-frames-per-second stereo X-ray imaging system., Co-invented patented technology related to dual fluoroscopy, quantitative MRI analysis, ultrasound eye scanning and eyelid control during ultrasound imaging.

## Career timeline

- **1994** — Completed a master's degree in electrical engineering at Delft University of Technology, with a specialization in information theory.
- **2001** — Completed a PhD in biomedical engineering at Boston University after dissertation work on postural control, then created a virtual-reality laboratory at the university's Sargent College.
- **2004** — Joined the Steadman-Hawkins Research Foundation in Vail and worked on a high-speed biplane fluoroscopy system for measuring joint motion.
- **2009** — Became acting president of the Rocky Mountain Chapter of the American College of Sports Medicine while serving as a senior staff scientist in biomechanics research.
- **2012** — Moved into the medical-device industry and later served Halifax Biomedical in engineering leadership and CTO roles, directing imaging, instrumentation, analysis-software and tele-radiology programs.
- **2019** — Joined ArcScan; as Vice President of Engineering, built the engineering function and brought R&D activities in-house.
- **2024** — Appointed Director and Chief Executive Officer of ArcScan in July, succeeding Andrew Levien.
- **2025** — Presented the principles and technical approach of ArcScan's Insight 100 at the system's China launch.

## Achievements

- Published more than 30 peer-reviewed articles across engineering and clinical journals.
- Built advanced academic research environments including a virtual-reality lab and a BioMotion Lab with a 1,000-frames-per-second stereo X-ray imaging system.
- Co-invented patented technology related to dual fluoroscopy, quantitative MRI analysis, ultrasound eye scanning and eyelid control during ultrasound imaging.
- Directed major medical-device programs spanning surgical instruments, stereo X-ray equipment, 3D image analysis, tele-radiology and a mobile imaging trailer.
- Established ArcScan's engineering function and brought its research and development activities in-house before becoming CEO.

## Latest updates

- **2025-09** — Participated in the China launch of the Insight 100, explaining the ultrasound-imaging principles and the system's technical approach.
- **2024-07** — Appointed Director and CEO of ArcScan, succeeding Andrew Levien after five years leading engineering at the company.
- **2024-05** — ArcScan announced Chinese NMPA approval for the Insight 100, a market Giphart was tasked with advancing alongside the United States.

## Links

- Website: https://www.arcscan.com/
- LinkedIn: https://www.linkedin.com/in/jerikgiphart

---

Profile page: https://yespress.io/erik-giphart
Published by YesPress — https://yespress.io
Last updated: 2026-09-28